Neha Krishnamohan
Director/Board Member bij ARCUTIS BIOTHERAPEUTICS, INC.
Vermogen: 55 565 $ op 31-03-2024
Actieve functies van Neha Krishnamohan
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Director/Board Member | 02-09-2022 | - |
| Independent Dir/Board Member | 02-09-2022 | - |
Loopbaan van Neha Krishnamohan
Eerdere bekende functies van Neha Krishnamohan
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| KINNATE BIOPHARMA INC. | Director of Finance/CFO | 07-06-2021 | 03-04-2024 |
| THE GOLDMAN SACHS GROUP, INC. | Corporate Officer/Principal | 01-07-2008 | 01-05-2021 |
Opleiding van Neha Krishnamohan
| Duke University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
Operationeel
| Director of Finance/CFO | 1 |
| Undergraduate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sectoraal
| Health Technology | 3 |
| Finance | 2 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| THE GOLDMAN SACHS GROUP, INC. | Finance |
| ARCUTIS BIOTHERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Kinnate Biopharma, Inc.
 Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Kinnate Biopharma, Inc. operates as a biopharmaceutical company engaged in the research and development of Kinnate Discovery Engine that targets genomic drivers of cancer. The company was founded by Stephen W. Kaldor and Eric A. Murphy in January 2018 and is headquartered in San Diego, CA. | Health Technology |
- Beurs
- Insiders
- Neha Krishnamohan
- Ervaring
